高危患者肝细胞癌无创诊断标准化算法的观察者间与检查方法间一致性:CEUS-LI-RADS 与 MRI-LI-RADS 对比
回顾性分析50例高危患者肝脏局灶性病变,比较CEUS-LI-RADS v.2016与MRI-LI-RADS v.2014的观察者间一致性。MRI-LI-RADS分类观察者间一致性为substantial(ĸ=0.609),CEUS-LI-RADS仅为fair(ĸ=0.309);两种方法间一致性fair至slight。作者认为可能需要进一步完善LI-RADS算法并加强培训以提高CEUS与MRI之间的一致性。
要点
- MRI-LI-RADS分类观察者间一致性为substantial(ĸ=0.609),CEUS-LI-RADS仅为fair(ĸ=0.309)。
- CEUS上动脉期高增强的观察者间一致性(ĸ=0.511)优于廓清表现(ĸ=0.490),MRI上廓清一致性(ĸ=0.582)优于CEUS。
- CEUS与MRI之间LI-RADS分类的一致性为fair(ĸ=0.218),廓清表现一致性为slight至fair(ĸ=0.202)。
核心结论
- MRI-LI-RADS的观察者间一致性为substantial,CEUS-LI-RADS仅为fair;这主要因为MRI对廓清表现的观察者间一致性优于CEUS。
研究设计与样本
- 回顾性研究,纳入50例高危患者的肝脏局灶性病变,两名独立观察者分别依据CEUS-LI-RADS v.2016和MRI-LI-RADS v.2014进行分类,采用Cohen's kappa评估观察者间一致性。
关键影像表现/征象
- CEUS上动脉期高增强的检出为观察者1 37/50(74%)、观察者2 38/50(78%),MRI为观察者1 46/50(92%)、观察者2 44/50(88%)。
- CEUS上廓清表现见于观察者1 34/50(68%)、观察者2 20/50(40%),MRI上两名观察者均为31/50(62%)。
- 43个病灶为肝细胞癌,2个为肝内胆管癌,5个为良性病变。
诊断标准与关键数值
- 动脉期高增强观察者间一致性:CEUS ĸ=0.511,MRI ĸ=0.565。
- 廓清表现观察者间一致性:CEUS ĸ=0.490,MRI ĸ=0.582。
- LI-RADS分类观察者间一致性:CEUS-LI-RADS ĸ=0.309(fair),MRI-LI-RADS ĸ=0.609(substantial)。
- 检查方法间一致性:动脉期高增强 ĸ=0.329(fair),廓清表现 ĸ=0.202(slight至fair),LI-RADS分类 ĸ=0.218(fair)。
临床应用与阅片要点
- 作者认为可能需要进一步完善LI-RADS算法并加强培训和实践,以提高CEUS与MRI之间最终LI-RADS分类的一致性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We compared the interobserver agreement for the recently introduced contrast-enhanced ultrasound (CEUS)-based algorithm CEUS-LI-RADS (Liver Imaging Reporting and Data System) versus the well-established magnetic resonance imaging (MRI)-LI-RADS for non-invasive diagnosis of hepatocellular carcinoma (HCC) in high-risk patients.
METHODS: Focal liver lesions in 50 high-risk patients (mean age 66.2 ± 11.8 years; 39 male) were assessed retrospectively with CEUS and MRI. Two independent observers reviewed CEUS and MRI examinations, separately, classifying observations according to CEUS-LI-RADSv.2016 and MRI-LI-RADSv.2014. Interobserver agreement was assessed with Cohen's kappa.
RESULTS: Forty-three lesions were HCCs; two were intrahepatic cholangiocarcinomas; five were benign lesions. Arterial phase hyperenhancement was perceived less frequently with CEUS than with MRI (37/50 / 38/50 lesions = 74%/78% [CEUS; observer 1/observer 2] versus 46/50 / 44/50 lesions = 92%/88% [MRI; observer 1/observer 2]). Washout appearance was observed in 34/50 / 20/50 lesions = 68%/40% with CEUS and 31/50 / 31/50 lesions = 62%/62%) with MRI. Interobserver agreement was moderate for arterial hyperenhancement (ĸ = 0.511/0.565 [CEUS/MRI]) and "washout" (ĸ = 0.490/0.582 [CEUS/MRI]), fair for CEUS-LI-RADS category (ĸ = 0.309) and substantial for MRI-LI-RADS category (ĸ = 0.609). Intermodality agreement was fair for arterial hyperenhancement (ĸ = 0.329), slight to fair for "washout" (ĸ = 0.202) and LI-RADS category (ĸ = 0.218) CONCLUSION: Interobserver agreement is substantial for MRI-LI-RADS and only fair for CEUS-LI-RADS. This is mostly because interobserver agreement in the perception of washout appearance is better in MRI than in CEUS. Further refinement of the LI-RADS algorithms and increasing education and practice may be necessary to improve the concordance between CEUS and MRI for the final LI-RADS categorization.
KEY POINTS: • CEUS-LI-RADS and MRI-LIRADS enable standardized non-invasive diagnosis of HCC in high-risk patients. • With CEUS, interobserver agreement is better for arterial hyperenhancement than for "washout". • Interobserver agreement for major features is moderate for both CEUS and MRI. • Interobserver agreement for LI-RADS category is substantial for MRI, and fair for CEUS. • Interobserver-agreement for CEUS-LI-RADS will presumably improve with ongoing use of the algorithm.
引用
- Schellhaas B, Hammon M, Strobel D, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018. PMID: 29675659. doi:10.1007/s00330-018-5379-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。